Efficacy and safety of vonoprazan–amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial

BACKGROUND: With the increase in antibiotic resistance, the success rate of Helicobacter pylori (H. pylori) eradication therapy has declined in recent years. Vonoprazan–amoxicillin (VA) dual therapy has been reported to be a promising regimen. OBJECTIVES: To compare the efficacy and safety of VA dua...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaolei, Teng, Guigen, Dong, Xinhong, Dai, Yun, Wang, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469240/
https://www.ncbi.nlm.nih.gov/pubmed/37664169
http://dx.doi.org/10.1177/17562848231190976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469240/
https://www.ncbi.nlm.nih.gov/pubmed/37664169
http://dx.doi.org/10.1177/17562848231190976

Ejemplares similares